Using native microbes as chassis for transgene delivery in live bacterial therapeutics

By | August 5, 2022
Residing within the human gut are trillions of bacteria and other microorganisms that can impact a variety of chronic human ailments, including obesity, type 2 diabetes, atherosclerosis, cancer, non-alcoholic fatty liver disease and inflammatory bowel disease.